ArticleCureus2026
Primary Gingival Squamous Cell Carcinoma With Secondary Extension Into the Maxillary Sinus, Orbit, and Skull Base: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gingival Squamous Cell Carcinoma: Diagnostic Challenges and Clinical Implications.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gingival squamous cell carcinoma (GSCC) is an uncommon oral malignancy that may mimic benign periodontal disease, often leading to delayed diagnosis and advanced stage presentation. We present a 68-year-old man with primary GSCC demonstrating extensive secondary invasion into the maxillary sinus, orbit, and skull base. He presented with progressive weakness, poor oral intake, cachexia, right facial numbness, and visual disturbances. His history was notable for a prolonged absence of medical and dental care due to financial barriers. Imaging revealed a large, destructive mass with orbital apex, cavernous sinus, and skull base involvement, consistent with aggressive perineural and intracranial spread, with regional metastasis to a level II cervical lymph node and distant osseous metastasis to the occipital bone. Given the extent of disease, the tumor was deemed unresectable and managed with systemic therapy, radiation, and corticosteroids for compressive optic neuropathy. This case highlights the aggressive potential of GSCC when diagnosis is delayed and emphasizes the critical role of early recognition and access to preventive care in improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.